Recent Finacing
Recent Raise
Cerebral Therapeutics develops implanted intracerebroventricular drug-device systems to deliver reformulated therapeutics (small molecules, oligonucleotides, antibodies, enzymes) directly to the brain, advancing CT-010 for refractory epilepsy in clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
